NI
STML

Numeric Investors’s Stemline Therapeutics, Inc. STML Stock Holding History

Numeric Investors’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-25,951
Closed -$509K – 943
2013
Q4 		$509K Buy
+25,951
New +$692K 0.01% 588

Other funds holding STML

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Numeric Investors's STML Position: Q1 2014 in Review

Numeric Investors sold out of Stemline Therapeutics, Inc. (STML) in Q1 2014, closing a stake of 25,951 shares — an estimated $509K sold.

Numeric Investors first reported a position in STML in Q4 2013 and held it in 1 quarter. The position peaked at $509K in Q4 2013. 61 funds tracked by Wall St. Rank hold STML as of Q1 2014.

  • Numeric Investors reported no remaining Stemline Therapeutics, Inc. position as of Q1 2014 after selling out during the quarter.
  • Numeric Investors sold 25,951 Stemline Therapeutics, Inc. shares in Q1 2014, an estimated $509K.
  • Numeric Investors first reported a position in Stemline Therapeutics, Inc. in Q4 2013 and held it in 1 quarter.
  • Numeric Investors's Stemline Therapeutics, Inc. position peaked at $509K in Q4 2013.
  • 61 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q1 2014.

Based on Numeric Investors's 13F filing for Q1 2014, filed 6 May 2014.